• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.

作者信息

Dance D A B, Davong V, Soeng S, Phetsouvanh R, Newton P N, Turner P

机构信息

Laos-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos Democratic People's Republic; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Laos-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos Democratic People's Republic.

出版信息

Int J Antimicrob Agents. 2014 Oct;44(4):368-9. doi: 10.1016/j.ijantimicag.2014.06.003. Epub 2014 Jul 21.

DOI:10.1016/j.ijantimicag.2014.06.003
PMID:25245211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4195405/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d7/4195405/4f9f340e13d1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d7/4195405/4f9f340e13d1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d7/4195405/4f9f340e13d1/gr1.jpg

相似文献

1
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.伯克霍尔德菌对甲氧苄啶/磺胺甲恶唑的耐药性
Int J Antimicrob Agents. 2014 Oct;44(4):368-9. doi: 10.1016/j.ijantimicag.2014.06.003. Epub 2014 Jul 21.
2
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.泰国伯克霍尔德菌临床分离株对甲氧苄啶/磺胺甲恶唑的耐药性
Int J Antimicrob Agents. 2015 May;45(5):557-9. doi: 10.1016/j.ijantimicag.2015.01.006. Epub 2015 Feb 16.
3
Mechanisms of Resistance to Folate Pathway Inhibitors in : Deviation from the Norm.叶酸代谢途径抑制剂耐药机制：偏离常态。
mBio. 2017 Sep 5;8(5):e01357-17. doi: 10.1128/mBio.01357-17.
4
Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.澳大利亚北领地首例类鼻疽伯克霍尔德菌分离株的当前抗菌药敏性。
Int J Antimicrob Agents. 2014 Aug;44(2):160-2. doi: 10.1016/j.ijantimicag.2014.04.012. Epub 2014 May 28.
5
The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.BpeEF-OprC 外排泵是导致临床和环境中广泛出现的假单胞菌属类鼻疽伯克霍尔德菌对甲氧苄啶耐药的原因。
Antimicrob Agents Chemother. 2013 Sep;57(9):4381-6. doi: 10.1128/AAC.00660-13. Epub 2013 Jul 1.
6
Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.越南北部伯克霍尔德菌分离株的药敏情况。
J Glob Antimicrob Resist. 2019 Sep;18:34-36. doi: 10.1016/j.jgar.2019.01.024. Epub 2019 Jan 24.
7
A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.用于检测伯克霍尔德菌属类鼻疽杆菌对复方新诺明药敏试验方法的比较。
Int J Antimicrob Agents. 2002 May;19(5):427-9. doi: 10.1016/s0924-8579(02)00016-x.
8
Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.北部昆士兰州伯克霍尔德氏菌临床分离株对美罗培南、头孢他啶、复方磺胺甲噁唑和强力霉素的微量肉汤稀释法的流行病学截断值。
J Glob Antimicrob Resist. 2017 Sep;10:291-294. doi: 10.1016/j.jgar.2017.04.012. Epub 2017 Jul 18.
9
Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.来自新加坡的50株伯克霍尔德菌临床分离株的抗生素敏感性
J Antimicrob Chemother. 2006 Nov;58(5):1102-3. doi: 10.1093/jac/dkl359. Epub 2006 Sep 2.
10
Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.来自澳大利亚北部热带地区的类鼻疽伯克霍尔德菌的抗生素敏感性及对类鼻疽治疗的意义。
Int J Antimicrob Agents. 2001 Feb;17(2):109-13. doi: 10.1016/s0924-8579(00)00334-4.

引用本文的文献

1
Global Prevalence of Antibiotic-Resistant in Melioidosis Patients: A Systematic Review and Meta-Analysis.类鼻疽病患者中抗生素耐药性的全球流行率：一项系统评价和荟萃分析。
Antibiotics (Basel). 2025 Jun 25;14(7):647. doi: 10.3390/antibiotics14070647.
2
Combatting melioidosis with chemical synthetic lethality.用化学合成致死性对抗类鼻疽病。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2406771121. doi: 10.1073/pnas.2406771121. Epub 2024 Nov 4.
3
Latent melioidosis activation presenting with urinary tract infection and bacteremia.

本文引用的文献

1
Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.澳大利亚北领地首例类鼻疽伯克霍尔德菌分离株的当前抗菌药敏性。
Int J Antimicrob Agents. 2014 Aug;44(2):160-2. doi: 10.1016/j.ijantimicag.2014.04.012. Epub 2014 May 28.
2
Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.复方磺胺甲噁唑与复方磺胺甲噁唑联合多西环素作为口服根除治疗类鼻疽（MERTH）的疗效比较：一项多中心、双盲、非劣效性、随机对照临床试验。
Lancet. 2014 Mar 1;383(9919):807-14. doi: 10.1016/S0140-6736(13)61951-0. Epub 2013 Nov 25.
3
以尿路感染和菌血症为表现的潜在类鼻疽激活。
IDCases. 2024 Jun 5;36:e02007. doi: 10.1016/j.idcr.2024.e02007. eCollection 2024.
4
The Rapid Emergence of Hypervirulent Species and as Major Health Threats in Southeast Asia: The Urgent Need for Recognition as Neglected Tropical Diseases.高毒力物种的迅速出现及其作为东南亚主要健康威胁的情况：迫切需要将其认定为被忽视的热带病。
Trop Med Infect Dis. 2024 Apr 8;9(4):80. doi: 10.3390/tropicalmed9040080.
5
Expression of virulence and antimicrobial related proteins in Burkholderia mallei and Burkholderia pseudomallei.马鼻疽伯克霍尔德菌和类鼻疽伯克霍尔德菌毒力和抗菌相关蛋白的表达。
PLoS Negl Trop Dis. 2023 Jan 6;17(1):e0011006. doi: 10.1371/journal.pntd.0011006. eCollection 2023 Jan.
6
Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: evidence to inform policy.老挝人民民主共和国人类和动物部门的抗菌药物使用和耐药数据：为政策提供信息的证据。
BMJ Glob Health. 2021 Nov;6(12). doi: 10.1136/bmjgh-2021-007009.
7
Enhanced melioidosis surveillance in patients attending four tertiary hospitals in Yangon, Myanmar.缅甸仰光四家三级医院就诊患者的类鼻疽强化监测。
Epidemiol Infect. 2021 Jun 22;149:1-23. doi: 10.1017/S095026882100128X.
8
Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates.伯氏菌属假单胞菌临床分离株中复方新诺明和美罗培南耐药的基因组和 RT-qPCR 分析。
PLoS Negl Trop Dis. 2021 Feb 16;15(2):e0008913. doi: 10.1371/journal.pntd.0008913. eCollection 2021 Feb.
9
Antimicrobial Susceptibility of Western Hemisphere Isolates of : Phenotypic and Genomic Analyses.西半球 ：表型和基因组分析的抗微生物敏感性。
Microb Drug Resist. 2021 Sep;27(9):1176-1185. doi: 10.1089/mdr.2020.0362. Epub 2021 Feb 10.
10
Burkholderia ubonensis Meropenem Resistance: Insights into Distinct Properties of Class A β-Lactamases in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Bacteria.乌本伯克霍尔德菌对美罗培南的耐药性：洋葱伯克霍尔德菌复合体和类鼻疽伯克霍尔德菌复合体细菌中 A 类β-内酰胺酶特性的研究进展。
mBio. 2020 Apr 14;11(2):e00592-20. doi: 10.1128/mBio.00592-20.
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.嗜麦芽窄食单胞菌临床分离株对甲氧苄啶/磺胺甲恶唑的耐药性
J Antimicrob Chemother. 2005 Jun;55(6):1029-31. doi: 10.1093/jac/dki151. Epub 2005 May 10.
4
A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.用于检测伯克霍尔德菌属类鼻疽杆菌对复方新诺明药敏试验方法的比较。
Int J Antimicrob Agents. 2002 May;19(5):427-9. doi: 10.1016/s0924-8579(02)00016-x.